Multicentre clinical trial to evaluate the analgesic efficacy and safety of Dexketoprofen [dexketoprofen trometamol] (50 mg t.i.d.) vs. Ketorolac (30 mg t.i.d.) by intravenous route as part of balanced analgesic therapy with morphine followed by oral dose administration in postoperative pain

Trial Profile

Multicentre clinical trial to evaluate the analgesic efficacy and safety of Dexketoprofen [dexketoprofen trometamol] (50 mg t.i.d.) vs. Ketorolac (30 mg t.i.d.) by intravenous route as part of balanced analgesic therapy with morphine followed by oral dose administration in postoperative pain

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Dexketoprofen (Primary) ; Dexketoprofen (Primary) ; Ketorolac; Ketorolac
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Menarini
  • Most Recent Events

    • 13 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top